You are here

Oral Vaccination Against Anthrax Using a Transgenic Plant Expressing Protective Antigen

Award Information
Agency: Department of Defense
Branch: Army
Contract: N/A
Agency Tracking Number: 28324
Amount: $739,710.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1996
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
1861 Pratt Drive, Suite 1040
Blacksburg, VA 24061
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Dr. Karen Oishi
 (703) 231-4325
Business Contact
Phone: () -
Research Institution
N/A
Abstract

Vaccines have significantly improved the health of animals and humans during the past century. However, there are still problems associated with cost, distribution and safety in administration of the vaccines, e.g., needle-stick injuries. Anthrax caused by Bacillus anthracis is a world-wide problem affecting both animals and humans. Although current anthrax vaccines for humans and animals have proven effective, recurring problems related to safety, cost, and drug delivery suggest the need for new approaches. The goal of this proposal is to develop transgenic plants for the production of oral (food-based) delivery of a new recombinant vaccine based on isolated DNA sequences coding for the highly immunogenic B. Anthracis protective antigen (PA). Specific objectives of Phase I are to 1) generate plant transformation/expression vectors encoding PA and a fusion protein of PA and CTB (the B subunit of cholera toxin which would facilitate PA transfer across o he gut mucosa), 2) introduce the PA and PA:CTB antigen genes into tobacco via Agrobacterium-mediated transformation, and 3) affinity-purify PA protein from transgenic tobacco tissue and assess its immunogenicity. Successful conclusion of Phase I objectives will provide a strong basis for scaled up recombinant vaccine production and testing planned for Phase II.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government